First Tracks Biotherapeutics
$40.88
4
-$0.97-2.31% 18:04 Today
Statistics
Day High
42.62
Day Low
40.75
52W High
49.91
52W Low
14.72
Volume
203,467
Avg. Volume
761,526
Mkt Cap
1.46B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q2 2026
Next
-0.95
-0.9
-0.85
-0.8
Expected EPS
-0.880565
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-50.48MNet Income
Analyst Ratings
60.50Average Price Target
The highest estimate is 95.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TRAX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
Show more...
CEO
Daniel R. Faga
Employees
104
Country
United States
ISIN
US3371851029
Listings
0 Comments
Share your thoughts
FAQ
What is First Tracks Biotherapeutics stock price today?▼
The current price of TRAX is $40.88 USD — it has decreased by -2.31% in the past 24 hours. Watch First Tracks Biotherapeutics stock price performance more closely on the chart.
What is First Tracks Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange First Tracks Biotherapeutics stocks are traded under the ticker TRAX.
What is First Tracks Biotherapeutics market cap?▼
Today First Tracks Biotherapeutics has the market capitalization of 1.46B
When is the next First Tracks Biotherapeutics earnings date?▼
First Tracks Biotherapeutics is going to release the next earnings report on December 02, 2026.
What were First Tracks Biotherapeutics earnings last quarter?▼
TRAX earnings for the last quarter are -0.95 USD per share, whereas the estimation was -0.8 USD resulting in a -18.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is First Tracks Biotherapeutics revenue for the last year?▼
First Tracks Biotherapeutics revenue for the last year amounts to 0 USD.
What is First Tracks Biotherapeutics net income for the last year?▼
TRAX net income for the last year is -50.48M USD.
How many employees does First Tracks Biotherapeutics have?▼
As of September 01, 2026, the company has 104 employees.
In which sector is First Tracks Biotherapeutics located?▼
First Tracks Biotherapeutics operates in the Health & Wellness sector.
When did First Tracks Biotherapeutics complete a stock split?▼
First Tracks Biotherapeutics has not had any recent stock splits.
Where is First Tracks Biotherapeutics headquartered?▼
First Tracks Biotherapeutics is headquartered in SAN DIEGO, United States.